))
31: Breaking the Stereotype around Psychedelics and Medicine with Tim Schlidt
Manage episode 404732120 series 3399208
Content provided by Dr. Neil Paulvin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Neil Paulvin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Schlidt is the cofounder and managing partner at Palo Santo, a venture capital fund focused exclusively on the advancement of psychedelic therapies for the treatment of mental health disorders and beyond. Based on his own experience with severe depression as a teenager, Schlidt's goal is to steward the most efficacious psychedelic therapies towards FDA approval so that patients may safely, legally, and affordably access these medicines. He has deployed $25 million into 20 companies including Gilgamesh, Journey Clinical and Sensorium.
Show Highlights:
-The potential of psychedelics for mental health treatment.
-Tim's story leading to investment in psychedelics.-Why to practice safe and supervised use of psychedelics in treatment.-Legal and ethical considerations around the use of psychedelics.
-What are challenges in developing psychedelics?-Predicitons for psychedelics in mainstream medicine.
-Psychedelics for therapeutic and personal growth.
34 episodes
Share
